Plaque Psoriasis Study

Plaque psoriasis is one of the most persistent and uncomfortable chronic skin conditions. Many individuals experience raised, red patches covered with silvery scales that commonly appear on the elbows, knees, scalp, and lower back, often causing itching, burning, and discomfort. Clinical Research Philadelphia is currently conducting a research study evaluating an investigational, oral, non-steroidal medication that may help reduce the symptoms of moderate to severe plaque psoriasis.

Get started now

  • Adults and teens 12 years or older

  • Diagnosed with moderate to severe plaque psoriasis

  • Have not used certain injectable medications for psoriasis (like Stelara®, Skyrizi®, Tremfya®)

  • May qualify if you've tried one oral or injectable treatment (like methotrexate or Otezla®) that didn't work or caused side effects

  • Willing to take a daily oral medication

  • Able to attend regular clinic visits in Philadelphia 

Who is it for?

  • Access to a potential new oral treatment at no cost

  • Close monitoring by experienced medical professionals

  • All study-related visits, labs, and procedures are covered

  • May experience improvement in psoriasis symptoms

  • Receive up to $1,000 in compensation for time and travel

Benefits for participants










Don’t see what you’re looking for?